{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Osborn J"],"funding":["National Institute of Diabetes and Digestive and Kidney Diseases","NIDDK NIH HHS"],"pagination":["995-1004"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9035582"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["6(5)"],"pubmed_abstract":["Children with biliary atresia (BA) often develop portal hypertension (PHT) and its complications, which are associated with high morbidity and mortality. The goal of this study was to identify serum biomarkers of PHT by using large-scale proteomics. We applied the slow off-rate modified aptamer scan (SOMAscan) to measure 1,305 proteins in serum samples of children with BA with and without clinical evidence of PHT in validation and discovery cohorts enrolled in the Biliary Atresia Study of Infants and Children. Serum proteomics data was analyzed using logistic regression to identify protein(s) with an area under the receiver operating characteristic curve (AUROC) ≥ 0.90. Immunostaining was used to characterize the cellular localization of the new biomarker proteins in liver tissues. We iden"],"journal":["Hepatology communications"],"pubmed_title":["Serum Proteomics Uncovers Biomarkers of Clinical Portal Hypertension in Children With Biliary Atresia."],"pmcid":["PMC9035582"],"funding_grant_id":["DK78392","T32 DK007727","T32 DK007727‐27","P30 DK078392","DK64008","DK62497","DK83781"],"pubmed_authors":["Osborn J","Shivakumar P","Bezerra JA","Mourya R","Thanekar U","Su W","Fei L"],"additional_accession":[]},"is_claimable":false,"name":"Serum Proteomics Uncovers Biomarkers of Clinical Portal Hypertension in Children With Biliary Atresia.","description":"Children with biliary atresia (BA) often develop portal hypertension (PHT) and its complications, which are associated with high morbidity and mortality. The goal of this study was to identify serum biomarkers of PHT by using large-scale proteomics. We applied the slow off-rate modified aptamer scan (SOMAscan) to measure 1,305 proteins in serum samples of children with BA with and without clinical evidence of PHT in validation and discovery cohorts enrolled in the Biliary Atresia Study of Infants and Children. Serum proteomics data was analyzed using logistic regression to identify protein(s) with an area under the receiver operating characteristic curve (AUROC) ≥ 0.90. Immunostaining was used to characterize the cellular localization of the new biomarker proteins in liver tissues. We iden","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 May","modification":"2026-05-10T01:34:56.068Z","creation":"2025-04-20T03:09:37.591Z"},"accession":"S-EPMC9035582","cross_references":{"pubmed":["34962102"],"doi":["10.1002/hep4.1878"]}}